🇺🇸 FDA
Patent

US 10195202

Methods for modulating the amount of RNA transcripts

granted A61KA61K31/4545A61K31/496

Quick answer

US patent 10195202 (Methods for modulating the amount of RNA transcripts) held by PTC THERAPEUTICS, INC. expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/4545, A61K31/496, A61K31/519, A61K31/5377